Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
dc.contributor.author | Inal, A | |
dc.contributor.author | Isikdogan, A | |
dc.contributor.author | Kos, T | |
dc.contributor.author | Algin, E | |
dc.contributor.author | Gumus, M | |
dc.contributor.author | Dikilitas, M | |
dc.contributor.author | Elkiran, ET | |
dc.contributor.author | Helvaci, K | |
dc.contributor.author | Geredeli, C | |
dc.contributor.author | Dane, F | |
dc.contributor.author | Balakan, O | |
dc.contributor.author | Durnali, AG | |
dc.contributor.author | Harputluoglu, H | |
dc.contributor.author | Goksel, G | |
dc.contributor.author | Ozdemir, N | |
dc.contributor.author | Buyukberber, S | |
dc.contributor.author | Yildiz, R | |
dc.contributor.author | Kaplan, MA | |
dc.contributor.author | Ozkan, M | |
dc.contributor.author | Uncu, D | |
dc.date.accessioned | 2024-07-18T12:07:54Z | |
dc.date.available | 2024-07-18T12:07:54Z | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | 1527-7755 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10676 | |
dc.language.iso | English | |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | |
dc.title | Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study | |
dc.type | Meeting Abstract |